nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.384	0.48	CbGbCtD
Sitagliptin—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.26	0.325	CbGbCtD
Sitagliptin—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.156	0.195	CbGbCtD
Sitagliptin—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.0107	0.0531	CcSEcCtD
Sitagliptin—Serum creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.008	0.0398	CcSEcCtD
Sitagliptin—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00653	0.0326	CcSEcCtD
Sitagliptin—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00541	0.027	CcSEcCtD
Sitagliptin—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00541	0.027	CcSEcCtD
Sitagliptin—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.0201	CcSEcCtD
Sitagliptin—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.0198	CcSEcCtD
Sitagliptin—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00375	0.0187	CcSEcCtD
Sitagliptin—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.0182	CcSEcCtD
Sitagliptin—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00357	0.0178	CcSEcCtD
Sitagliptin—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.0175	CcSEcCtD
Sitagliptin—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00335	0.0167	CcSEcCtD
Sitagliptin—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00326	0.0163	CcSEcCtD
Sitagliptin—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.0161	CcSEcCtD
Sitagliptin—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00303	0.0151	CcSEcCtD
Sitagliptin—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.0148	CcSEcCtD
Sitagliptin—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.0147	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.0143	CcSEcCtD
Sitagliptin—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.014	CcSEcCtD
Sitagliptin—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.0139	CcSEcCtD
Sitagliptin—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.0138	CcSEcCtD
Sitagliptin—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.0137	CcSEcCtD
Sitagliptin—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.0137	CcSEcCtD
Sitagliptin—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00274	0.0137	CcSEcCtD
Sitagliptin—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00271	0.0135	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.0027	0.0134	CcSEcCtD
Sitagliptin—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00268	0.0133	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.013	CcSEcCtD
Sitagliptin—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.0129	CcSEcCtD
Sitagliptin—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.0122	CcSEcCtD
Sitagliptin—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0122	CcSEcCtD
Sitagliptin—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.0122	CcSEcCtD
Sitagliptin—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.0121	CcSEcCtD
Sitagliptin—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.0121	CcSEcCtD
Sitagliptin—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.0112	CcSEcCtD
Sitagliptin—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.0111	CcSEcCtD
Sitagliptin—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.0108	CcSEcCtD
Sitagliptin—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.0107	CcSEcCtD
Sitagliptin—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.0106	CcSEcCtD
Sitagliptin—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.0105	CcSEcCtD
Sitagliptin—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00209	0.0104	CcSEcCtD
Sitagliptin—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.0103	CcSEcCtD
Sitagliptin—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.0101	CcSEcCtD
Sitagliptin—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00994	CcSEcCtD
Sitagliptin—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00979	CcSEcCtD
Sitagliptin—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00966	CcSEcCtD
Sitagliptin—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00963	CcSEcCtD
Sitagliptin—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.00935	CcSEcCtD
Sitagliptin—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00925	CcSEcCtD
Sitagliptin—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00912	CcSEcCtD
Sitagliptin—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00912	CcSEcCtD
Sitagliptin—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00909	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00906	CcSEcCtD
Sitagliptin—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00901	CcSEcCtD
Sitagliptin—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.00892	CcSEcCtD
Sitagliptin—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00874	CcSEcCtD
Sitagliptin—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00869	CcSEcCtD
Sitagliptin—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00858	CcSEcCtD
Sitagliptin—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00849	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00797	CcSEcCtD
Sitagliptin—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.00791	CcSEcCtD
Sitagliptin—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00777	CcSEcCtD
Sitagliptin—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00155	0.0077	CcSEcCtD
Sitagliptin—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0076	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.00755	CcSEcCtD
Sitagliptin—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00754	CcSEcCtD
Sitagliptin—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00748	CcSEcCtD
Sitagliptin—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00748	CcSEcCtD
Sitagliptin—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00721	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00715	CcSEcCtD
Sitagliptin—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00695	CcSEcCtD
Sitagliptin—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00691	CcSEcCtD
Sitagliptin—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00644	CcSEcCtD
Sitagliptin—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00126	0.00627	CcSEcCtD
Sitagliptin—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00598	CcSEcCtD
Sitagliptin—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00578	CcSEcCtD
Sitagliptin—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.00556	CcSEcCtD
Sitagliptin—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00551	CcSEcCtD
Sitagliptin—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00551	CcSEcCtD
Sitagliptin—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.00548	CcSEcCtD
Sitagliptin—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.00519	CcSEcCtD
